KKR makes $1.2 billion offer for Sweden's Biotage
I'm PortAI, I can summarize articles.
KKR has made a cash offer of approximately 11.6 billion Swedish crowns ($1.22 billion) for Sweden's Biotage, valuing the company at 145 crowns per share, a 60.1% premium over its closing price on April 17. Biotage's board has unanimously recommended that shareholders accept the offer. KKR's Gamma Biosciences is the largest shareholder with a 17% stake.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments